Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

Last updated: April 10, 2019
Sponsor: Rajaie Cardiovascular Medical and Research Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Coronary Artery Disease

Circulation Disorders

Low Blood Pressure (Hypotension)

Treatment

N/A

Clinical Study ID

NCT03830957
HFRC_01
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Sinus rhythm

  • Heart rate >60/min

Exclusion

Exclusion Criteria:

  • Atrial fibrillation

  • Any contraindication for beta-blocker use

Study Design

Total Participants: 200
Study Start date:
November 26, 2018
Estimated Completion Date:
December 31, 2019

Connect with a study center

  • Ahmad Amin

    Tehran, 1996911151
    Iran, Islamic Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.